Thierry E Appelboom: Influence Statistics

Thierry E Appelboom

Thierry E Appelboom

Hopital Erasme Brussels, Belgium. | University of Brussels, Belgium | Hopital Erasme, Brussels, Belgium. | Department of Rheumatology, Erasme Hospital, University of Brussels, ...

Thierry E Appelboom: Expert Impact

Concepts for which Thierry E Appelboom has direct influence: Rheumatoid arthritis , Femoral head , Salivary glands , Hyaluronic acid , Ankylosing spondylitis , Infliximab patients , Magnetic resonance .

Thierry E Appelboom: KOL impact

Concepts related to the work of other authors for which for which Thierry E Appelboom has influence: Rheumatoid arthritis , Femoral head , Ankylosing spondylitis , Bone marrow , Inosine pranobex , Autoimmune diseases , Sjögren syndrome .

KOL Resume for Thierry E Appelboom

Year
2016

Hopital Erasme Brussels, Belgium.

2014

University of Brussels, Belgium

2013

Hopital Erasme, Brussels, Belgium.

2012

Department of Rheumatology, Erasme Hospital, University of Brussels, 808 Route de Lennik, 1070, Brussels, Belgium

2009

Service de rhumatologie, hôpital Erasme, université Libre de Bruxelles, Bruxelles, Belgique

2007

Division of Rheumatology and Physical Medicine, Hôpital Erasme, Université libre de Bruxelles, Brussels, Belgium

2006

Division of Rheumatology and Physical Medicine, Hôpital Erasme, Université libre de Bruxelles, 808, Route de Lennik, 1070, Brussels, Belgium

2005

Erasmus Hospital, University of Brussels, Belgium.

Erasme University Hospital, B 1070 Brussels, Belgium

2003

2002

Erasmus University Hospital, University of Brussels, 808 route de Lennik, B-1070 Brussels, Belgium.

Division of Rheumatology, Université Libre de Bruxelles – Hôpital Erasme, Brussels, Belgium, Belgium

Erasme University Hospital

2001

Department of Rheumatology, Erasmus University Hospital of Brussels, Belgium.

2000

Division of Rheumatology, Erasme University Hospital, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium

1999

Hôpital Erasme, Department of Rheumatology, Université Libre de Bruxelles, 808 route de Lennik, B-1070, Brussels, Belgium

1998

Hopital Erasme; Brussels, Belgium

1997

From the Dept of Rheumatology, Erasmus Hospital, Free University of Brussels, Belgium

1996

From the Division of Rheumatology, Erasmus University Hospital, University of Brussels, Belgium

1995

Chief Division of Rheumatology, Erasmus University Hospital, University of Brussels, Brussels, Belgium

1994

Sleep Laboratory, Department of Psychiatry, Rheumatology Unit, Psychiatric Consultant, Erasme Hospital, Serolab, Lausanne, Switzerland;, IRIBHN, Brussels Free University, Brussels, Belgium

Division of Rheumatology, Erasmus Hospital, 808, route de Lennik, B-1070, Brussels

1993

Division of Rheumatology, Erasmus Hospital, University of Brussels, Brussels, Belgium

1992

Service de Rhumatologie, Hǒpital Erasme, School of Medicine, University of Brussels, Belgium

1991

Unit of Magnetic Resonance, School of Medicine, University of Brussels, Brussels, Belgium

1990

Division of Rheumatology, Erasmus Hospital, University of Brussels

1989

Division of Rheumatology, Erasmus University Hospital, University of Brussels, Belgium

1988

Division of Rheumatology, Erasmus University Hospital and Center for the Preservation and the Study of Medical Heritage, University of Brussels, Brussels, Belgium

1987

Erasmus University Hospital—University of Brussels 808, Route de Lennik B-1070, Brussels, Belgium

1986

USA

1984

Division of Rheumatology, Erasme University Hospital, Brussels, Belgium, and Metropolitan General Hospital, San Antonio, Tex., USA

Department of Immunology and Hematology, Erasme Hospital, Universite Libre de Bruxelles, 1070, Brussels, Belgium

1983

Service et Laboratoire de Rhumatologie, Hôpital Erasme, Université Libre de Bruxelles, 808 Route de Lennik, B-1070, Bruxelles, Belgium

1981

Fondation Robert Debré, Brussels, Belgium

1980

Cliniques Universitaires de Bruxelles, Hôpital Erasme, Université Libre de Bruxelles, Bruxelles Belgium

1979

Departments of Immunology and Rheumatology, Saint-Pierre University Hospital, Brussels, Belgium

1978

Departments of Rheumatology and Immunology, Hôpital Universitaire Saint-Pierre, UniversitéLibre de Bruxelles, 1000 Brussels, Belgium

Prominent publications by Thierry E Appelboom

KOL-Index: 11118 . OBJECTIVE: T cells are involved in the pathogenesis of rheumatoid arthritis (RA). In animal models of autoimmune diseases, blockade of costimulatory molecules on antigen-presenting cells has been demonstrated to be effective in preventing or treating this disease by preventing T cell activation. To date, the effect of costimulatory blockade in patients with RA is unknown. The goal of this ...
Known for Costimulatory Blockade | Rheumatoid Arthritis | Autoimmune Diseases | Cell Activation
KOL-Index: 11061 . OBJECTIVE: To study the relationship of spinal inflammation and fatty degeneration (FD) as detected by MRI and new bone formation seen on conventional radiographs (CRs) in ankylosing spondylitis (AS). METHODS: CRs at baseline, 2 years and 5 years and spinal MRIs at baseline and 2 years of 73 AS patients treated with infliximab in European AS Infliximab Cohort were available. Relative risks ...
Known for New Bone Formation | 2 Years | Ankylosing Spondylitis | Inflammation Baseline
KOL-Index: 9335 . Abstract. Although fluoride salts have been shown to be capable of linearly increasing spinal bone mineral density (BMD) in postmenopausal osteoporosis, the effects of this gain in density on the vertebral fracture rate remain controversial. We conducted a 2-year multicenter, prospective, randomized, double-masked clinical trial in 354 osteoporotic women with vertebral fractures (mean age ...
Known for Postmenopausal Osteoporosis | Vertebral Fractures | Fluoride Salts | 2 Years
KOL-Index: 7546 . Mycophenolate mofetil (MMF) is a new immunosuppressive agent currently used in organ transplantation and under evaluation in immune-mediated inflammatory disorders such as rheumatoid arthritis. Although MMF was shown to inhibit purine nucleotide synthesis in lymphocytes, it is still unclear whether it might also exert direct antiinflammatory actions in vivo. To address this question, we ...
Known for Mycophenolate Mofetil | Murine Endotoxemia | Antiinflammatory Properties | Inbred Balb Mice
KOL-Index: 7302 . OBJECTIVES: We compare the symptomatic effects of 300 or 600mg daily of ASU in patients with knee osteoarthritis. METHODS: A multicenter, double blind, study comparing a daily intake of 300mg or 600mg of ASU and placebo. The study lasted 3 months and involved patients of both genders, aged 45 to 80 years and presenting with femoro-tibial knee osteoarthritis. The primary endpoint was NSAIDs ...
Known for Asu Placebo | Knee Osteoarthritis | Daily Intake | Soybean Unsaponifiables
KOL-Index: 6737 . Various proteases are expressed in the minor salivary glands (MSG) of patients with Sjögren's syndrome (SS), and as we have already shown, prolactin is neosynthesized in the acinar cells of patients with SS. The present study aims to characterize the influence of PRL on the expression of cathepsin B and D in the MSG of patients with SS. Cathepsin B and D expression was investigated ...
Known for Salivary Glands | Expression Cathepsin | Sjögrens Syndrome | Prolactin Prl
KOL-Index: 6535 . OBJECTIVE: Tumor necrosis factor alpha (TNFalpha) is a proinflammatory cytokine involved in the pathogenesis of Sjögren's syndrome (SS), and blockade of TNFalpha may reduce the activity of the disease. The purpose of this study was to evaluate the safety and potential efficacy of infliximab, a chimeric human-mouse anti-TNFalpha monoclonal antibody, in patients with active primary ...
Known for Infliximab Patients | Primary Sjögren | Salivary Flow | Clinical Benefit
KOL-Index: 6084 . In this randomized, double-blind, double-dummy trial, 113 patients with acute sciatica were treated with a single 15-mg dose of meloxicam given intramuscularly (n = 54) or orally (n = 59). There was a significant improvement in induced pain (as measured by using the straight-leg-raising test) in both treatment groups at 60 minutes (P < 0.005), and there was a significant difference in ...
Known for Acute Sciatica | Oral Meloxicam | Intramuscular Formulation | Local Tolerability

Key People For Rheumatoid Arthritis

Top KOLs in the world
#1
Paul Emery
rheumatoid arthritis ankylosing spondylitis radiographic progression
#2
Josef Sebastian Smolen
rheumatoid arthritis systemic lupus erythematosus radiographic progression
#3
James F Fries
rheumatoid arthritis physical function systemic lupus erythematosus
#4
John Turner Sharp
rheumatoid arthritis radiographic progression joint space width
#5
Frederick J Wolfe
rheumatoid arthritis work disability rheumatic diseases
#6
Matthew H Liang
rheumatoid arthritis systemic lupus erythematosus lyme disease

Hopital Erasme Brussels, Belgium. | University of Brussels, Belgium | Hopital Erasme, Brussels, Belgium. | Department of Rheumatology, Erasme Hospital, University of Brussels, 808 Route de Lennik, 1070, Brussels, Belgium | Service de rhumatologie, hô